共 50 条
- [31] Engineering Anti-myeloma Responses Using Affinity-Enhanced TCR-Engineered T CellsCANCER CELL, 2015, 28 (03) : 281 - 283San Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Ctr Invest Med Aplicada, IDISNA, Pamplona 31008, Spain Univ Navarra Clin, Ctr Invest Med Aplicada, IDISNA, Pamplona 31008, SpainPaiva, Bruno论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Ctr Invest Med Aplicada, IDISNA, Pamplona 31008, Spain Univ Navarra Clin, Ctr Invest Med Aplicada, IDISNA, Pamplona 31008, SpainLasarte, Juan-Jose论文数: 0 引用数: 0 h-index: 0机构: Univ Navarra Clin, Ctr Invest Med Aplicada, IDISNA, Pamplona 31008, Spain Univ Navarra Clin, Ctr Invest Med Aplicada, IDISNA, Pamplona 31008, Spain
- [32] Mass-spectrometry-guided target selection and TCR profiling: towards the development of safer TCR-engineered T cell therapiesJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Demberg, Thorsten论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USAKalra, Mamta论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USAAlten, Leonie论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Tubingen, Germany Immat US Inc, Houston, TX USAAlpert, Amir论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USABunk, Sebastian论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Tubingen, Germany Immat US Inc, Houston, TX USAFritsche, Jens论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Tubingen, Germany Immat US Inc, Houston, TX USASchoor, Oliver论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Tubingen, Germany Immat US Inc, Houston, TX USAMaurer, Dominik论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Tubingen, Germany Immat US Inc, Houston, TX USAMohammed, Ali论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USABulliard, Yannick论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USASingh, Harpreet论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USAReinhardt, Carsten论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Martinsried, Germany Immat US Inc, Houston, TX USAWeinschenk, Toni论文数: 0 引用数: 0 h-index: 0机构: Immat Biotechnol GmbH, Tubingen, Germany Immat US Inc, Houston, TX USAWalter, Steffen论文数: 0 引用数: 0 h-index: 0机构: Immat US Inc, Houston, TX USA Immat US Inc, Houston, TX USA
- [33] Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challengesBIOMARKER RESEARCH, 2023, 11 (01)Pang, Zhi论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaLu, Man-man论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaZhang, Yu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaGao, Yuan论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaBai, Jin-jin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaGu, Jian-ying论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaXie, Lu论文数: 0 引用数: 0 h-index: 0机构: Shanghai Inst Biomed & Pharmaceut Technol, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 200237, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R ChinaWu, Wei-zhong论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Clin Ctr Biotherapy, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China
- [34] Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challengesBiomarker Research, 11Zhi Pang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationMan-man Lu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationYu Zhang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationYuan Gao论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationJin-jin Bai论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationJian-ying Gu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationLu Xie论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of EducationWei-zhong Wu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Liver Cancer Institute, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education
- [35] The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor ResponsesCELLS, 2020, 9 (07)Campillo-Davo, Diana论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol,Tumor Immunol Grp, B-2610 Antwerp, Belgium Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol,Tumor Immunol Grp, B-2610 Antwerp, BelgiumFlumens, Donovan论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol,Tumor Immunol Grp, B-2610 Antwerp, Belgium Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol,Tumor Immunol Grp, B-2610 Antwerp, Belgium论文数: 引用数: h-index:机构:
- [36] Transcriptional signatures in human melanoma epitope MART-127-35 specific TCR-engineered T cellsCANCER RESEARCH, 2014, 74 (19)Singh, Prashant论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAChakraborty, Nitya G.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAFarooq, Umar论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAHegde, Upendra P.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAEverson, Richard论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USADorsky, David I.论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USAMukherji, Bijay论文数: 0 引用数: 0 h-index: 0机构: Univ Connecticut, Ctr Hlth, Farmington, CT USA Univ Connecticut, Ctr Hlth, Farmington, CT USA
- [37] Two clinical trials of adoptive transfer of TCR-engineered T cells specific to MAGE-A4 and NY-ESO-1CANCER SCIENCE, 2018, 109 : 534 - 534Kageyama, Shinichi论文数: 0 引用数: 0 h-index: 0机构: Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, Japan论文数: 引用数: h-index:机构:Kitano, Shigehisa论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Expt Therapeut, Tokyo, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanMiyahara, Yoshihiro论文数: 0 引用数: 0 h-index: 0机构: Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanKato, Hidefumi论文数: 0 引用数: 0 h-index: 0机构: Aichi Med Univ, Nagakute, Aichi, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanMishima, Hideyuki论文数: 0 引用数: 0 h-index: 0机构: Aichi Med Univ, Nagakute, Aichi, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanYamamoto, Noboru论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Expt Therapeut, Tokyo, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanIwase, Hiroaki论文数: 0 引用数: 0 h-index: 0机构: Nagoya Med Ctr, Nagoya, Aichi, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanHattori, Hiroyoshi论文数: 0 引用数: 0 h-index: 0机构: Nagoya Med Ctr, Nagoya, Aichi, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanFunakoshi, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Keio Univ, Dermatol, Tokyo, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanKojima, Takashi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Gastroenterol, Kashiwa, Chiba, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, JapanWatanabe, Takashi论文数: 0 引用数: 0 h-index: 0机构: Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, Japan Mie Univ, Immunogene Ther, Grad Sch Med, Tsu, Mie, Japan论文数: 引用数: h-index:机构:
- [38] Enhancing Efficacy of TCR-engineered CD4+ T Cells Via Coexpression of CD8αJOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 132 - 144Anderson, Victoria E.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, 60 Jubilee Ave, Abingdon OX14 4RX, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandBrilha, Sara S.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandWeber, Anika M.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandPachnio, Annette论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandWiedermann, Guy E.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandDauleh, Sumaya论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandAhmed, Tina论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandPope, George R.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandQuinn, Laura L.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandDocta, Roslin Y.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandQuattrini, Adriano论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandMasters, Siobhan论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandCartwright, Neil论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandViswanathan, Preetha论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandMelchiori, Luca论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandRice, Louise V.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSevko, Alexandra论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandGueguen, Claire论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSaini, Manoj论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandTavano, Barbara论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandAbbott, Rachel J. M.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSilk, Jonathan D.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandLaugel, Bruno论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandSanderson, Joseph P.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, EnglandGerry, Andrew B.论文数: 0 引用数: 0 h-index: 0机构: Adaptimmune, Abingdon, Oxon, England Adaptimmune, Abingdon, Oxon, England
- [39] Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid LeukemiaCANCERS, 2021, 13 (18)Campillo-Davo, Diana论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, Belgium Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, BelgiumAnguille, Sebastien论文数: 0 引用数: 0 h-index: 0机构: Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, Belgium Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, B-2650 Edegem, Belgium Antwerp Univ Hosp, Div Hematol, B-2650 Edegem, Belgium Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, Belgium论文数: 引用数: h-index:机构:
- [40] TCR engineered T cells for solid tumor immunotherapyEXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2022, 11 (01)Zhang, Yikai论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R China Guangdong Cord Blood Bank, Guangzhou 510663, Peoples R China Jinan Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510632, Peoples R China Jinan Univ, Sch Med, Inst Hematol, Key Lab Regenerat Med,Minist Educ, 601 Huang Pu Dao Xi, Guangzhou 510632, Peoples R China Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R ChinaLiu, Zhipeng论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R China Guangdong Cord Blood Bank, Guangzhou 510663, Peoples R China Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R ChinaWei, Wei论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R China Guangdong Cord Blood Bank, Guangzhou 510663, Peoples R China Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R ChinaLi, Yangqiu论文数: 0 引用数: 0 h-index: 0机构: Jinan Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510632, Peoples R China Jinan Univ, Sch Med, Inst Hematol, Key Lab Regenerat Med,Minist Educ, 601 Huang Pu Dao Xi, Guangzhou 510632, Peoples R China Guangzhou Municipal Tianhe Nuoya Bioengn Co Ltd, Guangzhou 510663, Peoples R China